Pulsed electromagnetic field (PEMF) as an adjunct therapy for pain management in interstitial cystitis/bladder pain syndrome
| Autor: | Robert J. Evans, Tyler L. Overholt, Stephen J. Walker, Christina L Ross, Raymond Xu, Gopal H. Badlani, Catherine A. Matthews |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
030219 obstetrics & reproductive medicine business.industry Visual analogue scale Urology 030232 urology & nephrology Chronic pain Obstetrics and Gynecology Interstitial cystitis medicine.disease Low back pain Clinical trial 03 medical and health sciences Therapeutic approach 0302 clinical medicine medicine Physical therapy Body region medicine.symptom business Patellofemoral pain syndrome |
| Zdroj: | International Urogynecology Journal. 33:487-491 |
| ISSN: | 1433-3023 0937-3462 |
| Popis: | Patients with interstitial cystitis/bladder pain syndrome (IC/BPS) often experience chronic pelvic and even systemic pain that can be difficult to clinically manage. Pulsed electromagnetic field (PEMF) therapy, a non-invasive strategy that has shown significant efficacy for pain reduction in other chronic pain conditions, may provide benefit for pain management in patients with IC/BPS. PEMF delivery to patients occurs via a bio-electromagnetic-energy device which consists of a flexible mat (180 × 50 cm) that the patient lies on for systemic, full-body delivery and/or a flexible pad (50 × 15 cm) for targeted delivery to a specific body region (e.g., pelvic area). The duration of individual sessions, number of sessions per day, total number of sessions, and follow-up observation period vary between previously published studies. Positive outcomes are typically reported as a significant reduction in visual analog scale (VAS) pain score and functional improvement assessed using validated questionnaires specific to the condition under study. The use of PEMF has been evaluated as a therapeutic strategy for pain management in several clinical scenarios. Randomized, double-blinded, placebo-controlled trials have reported positive efficacy and safety profiles when PEMF was used to treat non-specific low back pain, patellofemoral pain syndrome, chronic post-operative pain, osteoarthritis-related pain, rheumatoid arthritis-related pain, and fibromyalgia-related pain. Based on these positive outcomes in a variety of pain conditions, clinical trials to evaluate whether PEMF can provide a safe, non-invasive therapeutic approach to improve symptoms of chronic pain and fatigue in patients with IC/BPS are warranted. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink